Multi-analyte controls in a non-human matrix, buffered and lyophilized.
The concentration of the controls is provided in the lot-specific certificate of analysis.
-
-
Specifications
-
Kit Contents
-
Documentation
-
References
|
Application(s)
|
|
Cytokines & Chemokines
,
Immunology/Inflammation
|
|
|
Analyte(s)
|
|
IFN-γ, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, IL-13, TNF-α
|
|
|
Species
|
|
Human
|
|
|
Plate Type
|
|
NA
|
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
|
Storage Condition
|
|
2-8 °C
|
|
|
Schedule B Code
|
|
3822.19.0000
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
Proinflammatory Panel 1 Human Control 1
|
2-8 °C
|
5 vial
(1 vial)
|
|
|
|
Proinflammatory Panel 1 Human Control 2
|
2-8 °C
|
5 vial
(1 vial)
|
|
|
|
Proinflammatory Panel 1 Human Control 3
|
2-8 °C
|
5 vial
(1 vial)
|
|
|
|
Product Inserts
|
|
|
|
Certificate of analysis
|
|
View More
|
|
SDS
|
|
|
|
Title
|
Journal
|
Year
|
|
Twenty-eight day repeated exposure of human 3D bronchial epithelial model to heated tobacco aerosols indicates decreased toxicological responses compared to cigarette smoke
|
|
|
|
A phase 1 study of prophylactic anakinra to mitigate ICANS in patients with large B-cell lymphoma
|
|
|
|
Viral Antigen and Inflammatory Biomarkers in Cerebrospinal Fluid in Patients With COVID-19 Infection and Neurologic Symptoms Compared With Control Participants Without Infection or Neurologic Symptoms
|
|
|
|
Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations
|
|
|
|
Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection
|
|
|
|
|
View All
|
Order Details
Catalog No
Size
Price in USD
Qty
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters